Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 40:291-297
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelm, M.
Right arrow Articles by Strauer, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelm, M.
Right arrow Articles by Strauer, B. E.

Incidence and clinical outcome of iatrogenic femoral arteriovenous fistulas

Implications for risk stratification and treatment

Malte Kelm, MD*,*, Stefan M. Perings, MD*, Thomas Jax, MD*, Thomas Lauer, MD*, Frank C. Schoebel, MD*, Matthias P. Heintzen, MD*, Christian Perings, MD* and Bodo E. Strauer, MD, FACC, FESC*

* Department of Medicine, Division of Cardiology, Pulmonary Disease and Angiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.



View larger version (15K):

[in a new window]
 
Figure 1 Rate of persistence of arteriovenous fistula (AVF). The time interval from acquisition to closure of AVF was analyzed by Kaplan-Meier analysis. Numbers in horizontal bar indicate the cumulative number of patients with AVF closure.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement